WBI Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,358
Closed -$320K 360
2025
Q3
$320K Buy
3,358
+489
+17% +$45K 0.08% 248
2025
Q2
$250K Sell
2,869
-5,768
-67% -$489K 0.06% 225
2025
Q1
$776K Buy
8,637
+1,701
+25% +$152K 0.2% 118
2024
Q4
$554K Buy
6,936
+680
+11% +$58.9K 0.14% 146
2024
Q3
$563K Buy
+6,256
New +$526K 0.14% 158
2024
Q1
Sell
-19,604
Closed -$1.61M 219
2023
Q4
$1.61M Buy
+19,604
New +$1.49M 0.32% 81
2014
Q4
Sell
-74,161
Closed -$4.59M 216
2014
Q3
$4.59M Buy
+74,161
New +$4.72M 0.14% 100

Other funds holding MDT

WBI Investments's MDT Position: Q4 2025 in Review

WBI Investments sold out of Medtronic (MDT) in Q4 2025, closing a stake of 3,358 shares — an estimated $320K sold.

WBI Investments first reported a position in MDT in Q3 2014 and held it in 7 quarters. The position peaked at $4.59M in Q3 2014. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • WBI Investments reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • WBI Investments sold 3,358 Medtronic shares in Q4 2025, an estimated $320K.
  • WBI Investments first reported a position in Medtronic in Q3 2014 and held it in 7 quarters.
  • WBI Investments's Medtronic position peaked at $4.59M in Q3 2014.
  • 2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on WBI Investments's 13F filing for Q4 2025, filed 13 Feb 2026.